Melanie Oey

TL;DR: Unrivaled expression levels, together with the chloroplast's insensitivity to enzymes that degrade bacterial cell walls and the elimination of the need to remove bacterial endotoxins by costly purification procedures, indicate that this is an effective plant-based production platform for next-generation antibiotics, which are urgently required to keep pace with rapidly emerging bacterial resistance.

TL;DR: The rapid accumulation of plastic waste is driving international demand for renewable plastics with superior qualities (e.g., full biodegradability to CO2 without harmful byproducts), as part of an expanding circular bioeconomy.

TL;DR: Key global technology drivers, the potential and theoretical limits of microalgal H2 production systems, emerging strategies to engineer next‐generation systems and how these fit into an evolving H2 economy are summarized.

TL;DR: Improved H2 production efficiency was achieved at increased solar flux densities and high cell densities which are best suited for microalgae production as light is ideally the limiting factor and the overall improved photon-to-H2 conversion efficiency is suggested.

TL;DR: A strategy is designed that allows the expression in plastids of proteins that are toxic to Escherichia coli, and the plastid-produced antibiotics efficiently kill pathogenic strains of Streptococcus pneumoniae, the causative agent of pneumonia, thus providing a promising strategy for the production of next-generation antibiotics in plants.